Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Kyorin executes license with LG Life Sciences for KRP-197

Oct. 31, 2005

Phase II data on tadalafil in the treatment of BPH

Oct. 17, 2005

Rho kinase inhibitor improves responses of the cavernosal smooth muscle in rats

Oct. 14, 2005

Chugai patent describes new vitamin D receptor agonists for urological disorders

Oct. 14, 2005

Urigen receives IND clearance for phase IIb study of U-101

Oct. 7, 2005

Tissue distribution of SVT-40776 indicates a good safety profile

Sep. 29, 2005

AVE-7688 reduces renal fibrosis in COL4A3-/- mice

Sep. 26, 2005

Tachykinin antagonists prepared and tested at Takeda

Sep. 22, 2005

Calcium-sensing receptor (CaSR) validated as a target for bladder dysfunction

Sep. 16, 2005

BXL-628 demonstrates efficacy in experimental autoimmune prostatitis

Sep. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...